- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04109638
Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery
A Pilot Prospective, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy in Decreasing Post-Operative Pain Following Orthopedic Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michelle Xiao, BS
- Phone Number: 6507230003
- Email: mxiao@stanford.edu
Study Locations
-
-
California
-
Redwood City, California, United States, 94063
- Recruiting
- Stanford University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subjects may be male or female greater or equal to 18 years of age (≥ 18) at the time of consent.
- Subjects who will be having shoulder or knee surgery are permitted.
Subject must not have used NSAIDs for one (1) week prior to surgery.
a. a. Low-dose aspirin (81 mg) is permitted.
- Subject must be willing and able to participate in post-operative physical therapy exercises.
- Subject must understand and be willing to sign the IRB-approved Informed Consent Document.
Exclusion Criteria:
- Subject has a known collagen disorder such as, but not limited to, osteogenesis imperfecta (OI) or Ehlers-Danlos syndrome (EDS).
- Subject has a known inflammatory or autoimmune connective tissue disease such as, but not limited to, gout affecting the shoulder, scleroderma, SLE, rheumatoid disease, or calcific tendonitis of the shoulder.
- Subject has a metabolic bone disease such as Paget's disease or osteomalacia as documented in the medical record.
- Subject has a deltoid defect, deltoid palsy or any other pseudoparalysis.
- Subject is diabetic.
- Subject has HIV or hepatitis.
- Subject has a diagnosis of fibromyalgia or other chronic pain syndrome.
- Subject has shoulder or knee pain of unknown etiology.
- Subject has had an active malignancy in the past 5 years OR has an active or on-going neoplastic disease, except for benign skin cancer(s).
- Subject has undergone administration, within 30 days prior to surgery, of any type of corticosteroid (with the exception of asthma medications and ophthalmic medications), antineoplastic, immunostimulation or immunosuppressive agent.
- Subject is septic, or has a local or systemic infection.
Subject has an admitted active substance abuse problem which includes recreational drugs and/or narcotics or a history of substance abuse where history is defined as "not under the care of a physician" for more than 5 years.
a. Prescriptive medical marijuana is not permitted, including CBD oils.
- Subject consumes more than 14 (men) or 7 (women) standard drinks (alcoholic units) per week where a drink equals a 12 oz. beer, or a 5 oz. glass of wine, or a 1.5 oz. shot of liquor.
- Subject is currently seeking or receiving worker's compensation for this injury or for an injury that has occurred more than 12 months prior to enrollment in this study or subjects who are currently in litigation or who have a history of litigation related to musculoskeletal diagnoses.
- Subject has major mental illnesses including major depression, bipolar disorder, schizophrenia or dementia that would prevent them from following the protocol and/or independently completing the patient reported outcomes measures.
- Subjects who have coexistent cervical spinal pathologies such as radiculopathies or myelopathies.
- Subject has a mental or physical condition that would prevent them from complying with the study protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active PEMF Group
Participants will have a 1 in 2 chance to get the active treatment device post-operatively.
The device will be attached to the post-operative dressing.
The device is an Endonovo SofPulse that emits a pulsed electromagnetic field (PEMF).
Single blind randomization.
|
The active device emits PEMF signal whereas the placebo device does not emit a PEMF signal.
The active device is on for 15 minutes at a time, every two hours, for 10 days.
Other Names:
|
Sham Comparator: Placebo PEMF Group
Participants will have a 1 in 2 chance to get the placebo treatment device post-operatively.
The device will be attached to the post-operative dressing.
The Endonovo SofPulse placebo device does not emit a pulsed electromagnetic field (PEMF).
Single blind randomization.
|
The active device emits PEMF signal whereas the placebo device does not emit a PEMF signal.
The active device is on for 15 minutes at a time, every two hours, for 10 days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change from baseline in pain scores on the visual analog scale (VAS) at 10 days
Time Frame: 10 days
|
The VAS is a subjective pain scale from 0 to 10, with 0 representing no pain.
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change from baseline in narcotic pain medicine use at 10 days
Time Frame: 10 days
|
Pain medication will be documented every 24 hours.
|
10 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Geoffrey D Abrams, MD, Stanford University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 53013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on Endonovo SofPulse
-
Amp Orthopedics, Inc.TerminatedKnee OsteoarthritisUnited States
-
University of PittsburghWithdrawnPostoperative Pain | Abdominal Body Contouring SurgeryUnited States
-
University of New MexicoWithdrawn
-
New York City Health and Hospitals CorporationCompleted
-
Columbia UniversityTerminatedShoulder Symptoms After Lymph Node DissectionUnited States
-
Columbia UniversityCompleted